3 | SEC Filings Hub

Filing metadata

Accession number: 0001062993-22-022492
Form type: Form 3
Filer: Acrivon Therapeutics, Inc.
CIK: CIK 1781174
Filed: Nov 18, 2022
Reporting period: Nov 17, 2022
Description: Initial ownership

Documents

0001062993-22-022492-index.htm

Complete submission

0001062993-22-022492.txt

directory listing

Filed by

Acrivon Therapeutics, Inc.